Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biocept Inc (BIOC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biocept Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1044378.
Total stock buying since 2015: $1,869,318.
Total stock sales since 2015: $2,453.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 445 | $1,809 | 0 | $0 |
| 2020 | 0 | $0 | 1,160 | $644 | 0 | $0 |
| 2018 | 25,000 | $0 | 0 | $0 | 0 | $0 |
| 2016 | 1,550,633 | $1,626,766 | 0 | $0 | 0 | $0 |
| 2015 | 152,667 | $242,552 | 0 | $0 | 152,927 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-12 | 0 | $0 | 445 | $1,809 | 0 | $0 |
| 2020-06 | 0 | $0 | 1,160 | $644 | 0 | $0 |
| 2018-01 | 25,000 | $0 | 0 | $0 | 0 | $0 |
| 2016-10 | 761,360 | $837,493 | 0 | $0 | 0 | $0 |
| 2016-05 | 789,273 | $789,273 | 0 | $0 | 0 | $0 |
| 2015-11 | 0 | $0 | 0 | $0 | 73,151 | $0 |
| 2015-08 | 0 | $0 | 0 | $0 | 39,286 | $0 |
| 2015-06 | 3,200 | $9,920 | 0 | $0 | 0 | $0 |
| 2015-05 | 1,800 | $5,490 | 0 | $0 | 40,490 | $0 |
| 2015-03 | 5,667 | $49,642 | 0 | $0 | 0 | $0 |
| 2015-02 | 142,000 | $177,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-09 | Hale David F (Director) | Sale | 445 | 4.07 | 1,809 |
| 2020-06-12 | Hale David F (Director) | Sale | 1,160 | .56 | 644 |
| 2018-01-30 | Gerhardt Bruce (Director) | Buy | 25,000 | .00 | 0 |
| 2016-10-19 | Kennedy Timothy (CFO, Sr V.P. Operations & Sec.) | Buy | 36,363 | 1.10 | 39,999 |
| 2016-10-19 | Singh Veena (Sr VP & Sr Med Director) | Buy | 10,000 | 1.10 | 11,000 |
| 2016-10-19 | Reiss Claire (10% Owner) | Buy | 227,272 | 1.10 | 249,999 |
| 2016-10-19 | Neff Edward A. (Director) | Buy | 227,272 | 1.10 | 249,999 |
| 2016-10-19 | Nall Michael W. (CEO & President) | Buy | 36,363 | 1.10 | 39,999 |
| 2016-10-19 | Chandler Marsha Alpert (Director) | Buy | 4,545 | 1.10 | 4,999 |
| 2016-10-19 | Gerhardt Bruce (Director) | Buy | 50,000 | 1.10 | 55,000 |
| 2016-10-19 | Wilson Margaret Faye (Director) | Buy | 13,636 | 1.10 | 14,999 |
| 2016-10-19 | Arnold Lyle J (SR VP of R&D and CSO) | Buy | 45,000 | 1.10 | 49,500 |
| 2016-10-19 | Huebner Bruce A (Director) | Buy | 20,000 | 1.10 | 22,000 |
| 2016-10-19 | Hale David F (Director) | Buy | 90,909 | 1.10 | 99,999 |
| 2016-05-04 | Reiss Claire (10% Owner) | Buy | 614,273 | 1.00 | 614,273 |
| 2016-05-04 | Neff Edward A. (Director) | Buy | 100,000 | 1.00 | 100,000 |
| 2016-05-04 | Gerhardt Bruce (Director) | Buy | 25,000 | 1.00 | 25,000 |
| 2016-05-04 | Hale David F (Director) | Buy | 50,000 | 1.00 | 50,000 |
| 2015-11-09 | Royston Ivor (Director) | Option Ex | 9,285 | .00 | 0 |
| 2015-11-09 | Hale David F (Chairman) | Option Ex | 63,866 | .00 | 0 |
| 2015-08-24 | Nall Michael W. (CEO & President) | Option Ex | 14,286 | .00 | 0 |
| 2015-08-24 | Arnold Lyle J (SR VP of R&D and CSO) | Option Ex | 10,714 | .00 | 0 |
| 2015-08-24 | Hale David F (Chairman) | Option Ex | 14,286 | .00 | 0 |
| 2015-06-01 | Singh Veena (Sr VP & Sr Med Director) | Buy | 3,200 | 3.10 | 9,920 |
| 2015-05-29 | Singh Veena (Sr VP & Sr Med Director) | Buy | 1,800 | 3.05 | 5,490 |
| 2015-05-24 | Neff Edward A. (Director) | Option Ex | 8,735 | .00 | 0 |
| 2015-05-24 | Gerhardt Bruce (Director) | Option Ex | 8,735 | .00 | 0 |
| 2015-05-24 | Wilson Margaret Faye (Director) | Option Ex | 14,285 | .00 | 0 |
| 2015-05-24 | Royston Ivor (Director) | Option Ex | 8,735 | .00 | 0 |
| 2015-03-16 | Royston Ivor (Director) | Buy | 5,667 | 8.76 | 49,642 |
| 2015-02-13 | Neff Edward A. (Director) | Buy | 40,000 | 1.25 | 50,000 |
| 2015-02-13 | Nall Michael W. (CEO & President) | Buy | 12,000 | 1.25 | 15,000 |
| 2015-02-13 | Chandler Marsha Alpert (Director) | Buy | 2,000 | 1.25 | 2,500 |
| 2015-02-13 | Gerhardt Bruce (Director) | Buy | 20,000 | 1.25 | 25,000 |
| 2015-02-13 | Wilson Margaret Faye (Director) | Buy | 4,000 | 1.25 | 5,000 |
| 2015-02-13 | Huebner Bruce A (Director) | Buy | 12,000 | 1.25 | 15,000 |
| 2015-02-13 | Royston Ivor (Director) | Buy | 12,000 | 1.25 | 15,000 |
| 2015-02-13 | Hale David F (Chairman) | Buy | 40,000 | 1.25 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BIOC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biocept Inc (symbol BIOC, CIK number 1044378) see the Securities and Exchange Commission (SEC) website.